Indication: CYTOPOINT aids in the reduction of clinical signs associated with atopic dermatitis in dogs.
*Repeat administration every 4 to 8 weeks as needed in the individual patient.1
Reference: 1. Data on file, Study Report No. C863R-US-12-018, Zoetis LLC.
The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries.
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted.
Zoetis Services LLC. All rights reserved. CYT-00090